CLEVELAND, Ohio — Nationally, respiratory syncytial virus and COVID-19 activity remains relatively low, due to population immunity, new vaccines for respiratory syncytial virus, and no new virulent ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

What Strain(s) Will The Vaccines Protect Against? The updated vaccines will target the JN.1 lineage of COVID-19, using the LP.8.1 strain. This lineage is a descendant of the Omicron variant of the ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

This fall, a federal vaccine advisory panel changed recommendations, saying Americans six months and older should discuss the risks and benefits with their health care providers. The move walked back ...

COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.

Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were found to be most protective four weeks after vaccination, providing ...

You’re not imagining it: The rollout of COVID-19 vaccines in 2025 has not been like previous years. But the big thing to know is that despite initial restrictions, California has now opened up access ...

A M Health Fairview nurse gives a Pfizer-BioNTech booster shot at a pop-up COVID-19 vaccination at Brian Coyle Center in M Health Fairview in Minneapolis. When it comes to staying informed in ...

5 Years Later: What Caused COVID-19? The World Health Organization called COVID-19 a pandemic for the first time five years ago today. The origin of COVID-19 is still unknown, though the leading ...